Treatment with MAGE-A1 KLV/A2 TCR, MAGE-A1 SLF/A3 TCR, and MAGE-A1 VRF/C7 TCR-T cells demonstrated a major antitumor effect, with tumor cells becoming undetectable between day 3 and 8 after T cell infusion (Figures 6A–6D). This evidence concerns the gene MAGEA1 and neoplasm.